ROCKET PHARMACEUTICALS, INC. (RCKT) is a publicly traded company in the Unknown sector. Across all available filings, 21 corporate insiders have executed 207 transactions totaling $108.1M, demonstrating a bearish sentiment with -$10.1M in net insider flow. The most recent transaction on Feb 18, 2026 involved a sale of 1,376 shares valued at $4.6K.
No significant insider buying has been recorded for RCKT in the recent period.
No significant insider selling has been recorded for RCKT in the recent period.
Based on recent SEC filings, insider sentiment for RCKT is bearish with an Insider Alignment Score of 45/100 and a net flow of -$10.1M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at ROCKET PHARMACEUTICALS, INC. (RCKT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 21 insiders are actively trading RCKT stock, having executed 207 transactions in the past 90 days. The most active insider is Investments, Lp Rtw (Executive), who has made 14 transactions totaling $112.8M.
Get notified when executives and directors at RCKT file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Wilson Martin | General Counsel | Sale | 1,376 | $3.34 | $4.6K | |
| Nov 18, 2025 | Wilson Martin | Executive | Sale | 1,646 | $2.98 | $4.9K | |
| Nov 18, 2025 | Shah Gaurav | Executive | Sale | 6,276 | $2.98 | $18.7K | |
| Nov 18, 2025 | David Schwartz Jonathan | Executive | Sale | 2,545 | $2.98 | $7.6K | |
| Nov 18, 2025 | Militello John | Executive | Sale | 1,086 | $2.98 | $3.2K | |
| Nov 3, 2025 | Wilson Martin | Executive | Award | 100,000 | $N/A | $0 | |
| Oct 14, 2025 | Militello John | Executive | Sale | 5,514 | $3.97 | $21.9K | |
| Oct 14, 2025 | Militello John | Executive | Sale | 3,005 | $3.97 | $11.9K | |
| Oct 14, 2025 | Militello John | Executive | Sale | 558 | $3.98 | $2.2K | |
| Oct 14, 2025 | Militello John | Executive | Sale | 19,841 | $3.96 | $78.6K | |
| Oct 6, 2025 | Ali-aamir Rizvi Syed | Executive | Award | 283,018 | $N/A | $0 | |
| Oct 6, 2025 | Ali-aamir Rizvi Syed | Executive | Award | 62,893 | $N/A | $0 | |
| Sep 24, 2025 | Fong Peter | Executive | Award | 30,000 | $N/A | $0 | |
| Sep 24, 2025 | Fong Peter | Executive | Award | 23,333 | $N/A | $0 | |
| Sep 19, 2025 | Lp Rtw Investments, | Executive | Exercise | 59,000 | $17.81 | $1.1M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 80 | $59.1M | 24.1% |
Purchase(P) | 8 | $49.0M | 20.0% |
Award(A) | 31 | $42.8M | 17.5% |
Exercise (Options)(X) | 3 | $41.9M | 17.1% |
Other(J) | 20 | $41.3M | 16.9% |
Payment(F) | 14 | $9.6M | 3.9% |
Exercise(M) | 41 | $1.4M | 0.6% |
Gift(G) | 10 | $0 | 0.0% |
Insider activity at ROCKET PHARMACEUTICALS, INC. shows mixed signals across all time. While $49.0M in purchases indicates some executive confidence,$59.1M in sales balances the picture, resulting in a modest net flow of -$10.1M.21 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Investments, Lp Rtw, has transacted $112.8M during this period.